RxDoctor Payments Data

Susan Little

Internal Medicine · San Diego, CANPI 1033134572

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $93,855 of the $95,234 with a category attached, or 98.6%. Every reported general payment came from a single manufacturer, Gilead. Reporting peaked in 2021 at $43,028 and has fallen 88.7% since, to $4,868 in 2023. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$95,234in general payments, 2019–2025

Across 24 payments — averaging $3968.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$95K
$1,461,919in research payments, 2019–2025

Across 39 payments — averaging $37,485 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$1.4M
  • Cue Health Inc.$9K
  • Pfizer$4K

What the payments were for

  • Consulting fees$93,85599%
  • Travel & lodging$9271%
  • Food & beverage$4520%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead24$95,234

How this compares

$95,234 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California →

Other internal medicine in San Diego

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →